Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
Eichhorst B, Niemann CU, Kater AP, Fürstenau M, von Tresckow J, Zhang C, Robrecht S, Gregor M, Juliusson G, Thornton P, Staber PB, Tadmor T, Lindström V, da Cunha-Bang C, Schneider C, Poulsen CB, Illmer T, Schöttker B, Nösslinger T, Janssens A, Christiansen I, Baumann M, Frederiksen H, van der Klift M, Jäger U, Leys MBL, Hoogendoorn M, Lotfi K, Hebart H, Gaska T, Koene H, Enggaard L, Goede J, Regelink JC, Widmer A, Simon F, De Silva N, Fink AM, Bahlo J, Fischer K, Wendtner CM, Kreuzer KA, Ritgen M, Brüggemann M, Tausch E, Levin MD, van Oers M, Geisler C, Stilgenbauer S, Hallek M; GCLLSG, the HOVON and Nordic CLL Study Groups, the SAKK, the Israeli CLL Association, and Cancer Trials Ireland. Eichhorst B, et al. Among authors: hoogendoorn m. N Engl J Med. 2023 May 11;388(19):1739-1754. doi: 10.1056/NEJMoa2213093. N Engl J Med. 2023. PMID: 37163621 Clinical Trial.
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
van der Straten L, Stege CAM, Kersting S, Nasserinejad K, Dubois J, Dobber JA, Mellink CHM, van der Kevie-Kersemaekers AF, Evers LM, de Boer F, Koene HR, Schreurs J, van der Klift M, Velders GA, van der Spek E, van der Straaten HM, Hoogendoorn M, van Gelder M, Posthuma EFM, Visser HPJ, Houtenbos I, Idink CAM, Issa DE, Dompeling EC, van Zaanen HCT, Veelken JH, Levenga H, Tick LW, Terpstra WE, Tonino SH, Westerweel PE, Langerak AW, Kater AP, Levin MD. van der Straten L, et al. Among authors: hoogendoorn m. Blood. 2023 Sep 28;142(13):1131-1142. doi: 10.1182/blood.2023020195. Blood. 2023. PMID: 37363833
The GLOW trial in chronic lymphocytic leukaemia.
van Gelder M, Hoogendoorn M, Te Raa D. van Gelder M, et al. Among authors: hoogendoorn m. Lancet Oncol. 2024 Feb;25(2):e55. doi: 10.1016/S1470-2045(23)00677-0. Lancet Oncol. 2024. PMID: 38301697 No abstract available.
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.
Lübbert M, Wijermans PW, Kicinski M, Chantepie S, Van der Velden WJFM, Noppeney R, Griškevičius L, Neubauer A, Crysandt M, Vrhovac R, Luppi M, Fuhrmann S, Audisio E, Candoni A, Legrand O, Foà R, Gaidano G, van Lammeren-Venema D, Posthuma EFM, Hoogendoorn M, Giraut A, Stevens-Kroef M, Jansen JH, de Graaf AO, Efficace F, Ammatuna E, Vilque JP, Wäsch R, Becker H, Blijlevens N, Dührsen U, Baron F, Suciu S, Amadori S, Venditti A, Huls G; EORTC Leukemia Group, GIMEMA, and German MDS Study Group. Lübbert M, et al. Among authors: hoogendoorn m. Lancet Haematol. 2023 Nov;10(11):e879-e889. doi: 10.1016/S2352-3026(23)00273-9. Lancet Haematol. 2023. PMID: 37914482 Free article. Clinical Trial.
Reinforcement learning for intensive care medicine: actionable clinical insights from novel approaches to reward shaping and off-policy model evaluation.
Roggeveen LF, Hassouni AE, de Grooth HJ, Girbes ARJ, Hoogendoorn M, Elbers PWG; Dutch ICU Data Sharing Against COVID-19 Collaborators. Roggeveen LF, et al. Among authors: hoogendoorn m. Intensive Care Med Exp. 2024 Mar 25;12(1):32. doi: 10.1186/s40635-024-00614-x. Intensive Care Med Exp. 2024. PMID: 38526681 Free PMC article.
Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the consecutive stages of the COVID-19 pandemic in the Netherlands, an update.
Termorshuizen F, Dongelmans DA, Brinkman S, Bakhshi-Raiez F, Arbous MS, de Lange DW, van Bussel BCT, de Keizer NF; Dutch COVID-19 Research Consortium. Termorshuizen F, et al. Ann Intensive Care. 2024 Jan 16;14(1):11. doi: 10.1186/s13613-023-01238-2. Ann Intensive Care. 2024. PMID: 38228972 Free PMC article.
Quality improvement of Dutch ICUs from 2009 to 2021: A registry based observational study.
Roos-Blom MJ, Bakhshi-Raiez F, Brinkman S, Arbous MS, van den Berg R, Bosman RJ, van Bussel BCT, Erkamp ML, de Graaff MJ, Hoogendoorn ME, de Lange DW, Moolenaar D, Spijkstra JJ, de Waal RAL, Dongelmans DA, de Keizer NF. Roos-Blom MJ, et al. Among authors: hoogendoorn me. J Crit Care. 2024 Feb;79:154461. doi: 10.1016/j.jcrc.2023.154461. Epub 2023 Nov 10. J Crit Care. 2024. PMID: 37951771 Free article.
235 results